UC Davis Assist Livermore Lab in Tech-Transfer Awards

East Bay Business Times - February 11, 2008
http://eastbay.bizjournals.com/eastbay/stories/2008/02/11/daily10.html
Monday, February 11, 2008 - 12:19 PM PST
Livermore lab gets tech-transfer awards
East Bay Business Times

Researchers at Lawrence Livermore National Laboratory will receive two awards for successful technology transfers to businesses.

The awards are given out by the Federal Laboratory Consortium, which is made up of more than 250 federal government laboratories.
LLNL won for developing the first compact proton-therapy system for treating cancer patients, and the first portable neutron detector that can assist in detecting illegal nuclear materials.

The cancer therapy system, developed in collaboration with the University of California Davis Cancer Center, is compact enough to fit in any major cancer center and comes at about one-fifth the cost of a full-scale machine, the lab said in its announcement.

Conventional proton therapy facilities require 90,000 square feet and cost more than $100 million to build, the lab said. The Livermore system is in a lightweight structure about 6.5 feet long.

The technology was licensed in February 2007 to TomoTherapy Inc. (NASDAQ: TTPY) of Madison, Wis., through an agreement with the University of California Regents.
The nuclear-materials detection system was LLNL-developed technology licensed to the Advanced Measurement Technology ORTEC division of Ametek Inc., of Oak Ridge, Tenn. That resulted in the ORTEC Fission Meter, a portable neutron detector that can identify fissile neutron sources such as uranium and plutonium, and can differentiate between weapons-usable materials and other items.

The awards will be presented May 8 during four-day national technology-transfer meeting in Portland, Ore.

The Federal Laboratory Consortium was established in 1974 to facilitate the transfer of federal lab technology to the public and private sectors.


All contents of this site © American City Business Journals Inc. All rights reserved.